Standout Papers
- Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. (2001)
Immediate Impact
10 by Nobel laureates 18 from Science/Nature 66 standout
Citing Papers
The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology
2024 Standout
Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras
2023 StandoutScienceNobel
Works of Peter Bross being referenced
Velcade®: U.S. FDA Approval for the Treatment of Multiple Myeloma Progressing on Prior Therapy
2003
Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.
2001 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Peter Bross | 588 | 676 | 458 | 12 | 1.4k | |
| Haleh Saber | 591 | 613 | 268 | 20 | 1.5k | |
| Changpu Yu | 658 | 719 | 183 | 22 | 1.5k | |
| B Soehnlen | 512 | 581 | 269 | 15 | 1.2k | |
| M. A. Baker | 398 | 695 | 248 | 18 | 1.5k | |
| Janis Liebetanz | 386 | 966 | 396 | 11 | 1.6k | |
| Nida Iqbal | 570 | 521 | 113 | 11 | 1.3k | |
| Tiffany K. Ricks | 754 | 524 | 239 | 20 | 1.7k | |
| Audie Rice | 648 | 818 | 519 | 28 | 1.6k | |
| Beverly D. Smolich | 396 | 962 | 471 | 17 | 1.7k | |
| Melanie Cornejo | 377 | 1009 | 273 | 19 | 1.6k |
All Works
Loading papers...